Skip to content

Clinical trials

Hematologic Diseases trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Country / region: Greece Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20171
20193
20211
20224
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Recruiting4
Unknown status3
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hellenic Society of Hematology4
Pfizer2
Takeda2
Amgen1
Athens LifeTech Park1
Cellectar Biosciences, Inc.1
Forma Therapeutics, Inc.1
Novartis Pharmaceuticals1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases14
Multiple Myeloma7
Blood Protein Disorders6
Neoplasms6
Neoplasms, Plasma Cell6
Paraproteinemias6
Hemorrhagic Disorders3
Anemia, Sickle Cell2
Autoimmune Diseases2
Blood Platelet Disorders2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.